Last update 23 Jan 2025

Globo H x Tubulin

Basic Info

Related Targets
Globo HTubulin

Related

2
Drugs associated with Globo H x Tubulin
OBI-999
Target
Globo H x Tubulin
Mechanism
Globo H inhibitors [+1]
Active Org.
OBI Pharma, Inc.OBI Pharma, Inc.
Originator Org.
Obi
Active Indication
Solid tumor
Inactive Indication
Locally Advanced Malignant Solid Neoplasm
Drug Highest PhasePhase 1/2
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
Globo H ADC(Development Center for Biotechnology)
Target
Globo H x Tubulin
Mechanism
Globo H inhibitors [+1]
Active Org.
Development Center for BiotechnologyDevelopment Center for Biotechnology
Originator Org.
Development Center for BiotechnologyDevelopment Center for Biotechnology
Active Indication
Neoplasms
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with Globo H x Tubulin
NCT04084366
/ TerminatedPhase 1/2
A Phase 1/2, Open-Label, Dose-Escalation and Cohort-Expansion Study Evaluating the Safety, Pharmacokinetics, and Therapeutic Activity of OBI-999 in Patients with Advanced Solid Tumors
100 Clinical Results associated with Globo H x Tubulin
Login to view more data
100 Translational Medicine associated with Globo H x Tubulin
Login to view more data
0 Patents (Medical) associated with Globo H x Tubulin
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free